Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #98786 on Biotech Values
DewDiligence
07/14/10 11:05 PM
#98836 RE: genisi #98786
Effient was expected to be a blockbuster, but in its first three quarters on the market sales have totaled just $35 million. By contrast, Plavix, sold by Bristol-Myers Squibb and Sanofi Aventis, has billions of dollars in annual sales.
Mr. Schaefer of Lilly, who said Effient sales were improving, said the [Accumetrics diagnostic] collaboration was not aimed at Plavix…